Market Overview

China $30 Bn Cancer Drugs Market 2018-2024 by Drugs, Cancer, Therapy, and Companies -


The "China
Cancer Drugs Market, by Drugs, Cancer, Therapy, and Companies"

report has been added to's

Anti-Cancer drugs are the drugs which are used to reduce or prevent the
cell proliferation of cancerous tissues. China Cancer Drugs Market is
projected to reach US$ 30 Billion by the year 2024; owing to the
increasing prevalence of various types of cancer, changing lifestyle &
dietary habits, growing aging population, rising demand of targeted drug
therapy and the patent expiration of key cancer drugs. Cancer is one of
the leading causes of death worldwide and is a major public health
burden in both developed and developing countries.

The rate of cancer incidences in China is exploding very rapidly; nearly
4 million people diagnosed and almost 3 million died from it. For
instance, due to increasing air pollution over the last couple of years,
lung cancer has increased 50% in Beijing only. Anticancer drugs act like
an inhibitor that prevents cancer cells to grow.

In addition, factors like growing awareness regarding cancer diagnosis &
treatment, advancement in cancer drugs and therapies, rise in cancer
awareness programs like breast cancer screening, investment in
healthcare infrastructure are expected to drive China anti-cancer drugs
market positively over the forecast period. However, major side-effects
of cancer drugs and its high cost are certainly restraining the China
anti-cancer drugs market to reach its full potential.

This market research report provides a complete analysis of the China
Cancer Drugs Market, Growth Drivers, Challenges, and their projections
for the upcoming years.

By Drugs

  • Cytotoxic Drugs
  • Antimetabolities
  • Plant Alkaloids
  • Alkylating Agents
  • Targeted Drugs
  • Monoclonal Antibiotics
  • Hormonal Drugs
  • Traditional Chinese Medicine (TCM)
  • Others

By Cancer

  • Lung Cancer
  • Stomach Cancer
  • Breast Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Others

By Therapy

  • Chemotherapy
  • Targeted Therapy
  • Hormonal Therapy
  • Others

Companies Covered in the Report

  • Merck
  • Celegene
  • Eli Lilly
  • Roche
  • Sino BioPharma

For more information about this report visit

View Comments and Join the Discussion!